Physician profile
Nitin Garg
NPI 1891914206
$9,274.88
in general payments reported to CMS, 2019-2025
28 companies · $326 in 2025
The $326 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,149 · 2020: $446 · 2021: $777 · 2022: $1,234 · 2023: $2,653 · 2024: $690 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,812 · Travel and Lodging: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,812.45 |
| Travel and Lodging | $856.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $2,355.18 | 2019 | |
| Penumbra, INC. | $2,157.97 | 2023-2025 | Indigo System, Penumbra System |
| W. L. Gore & Associates, INC. | $1,513.64 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Conformable Thoracic Endoprosthesis |
| Medtronic, INC. | $624.78 | 2021-2024 | Hawkone, Endurant Iis, Abre |
| Abbott Laboratories | $514.84 | 2020-2023 | Mitraclip, Gallant |
| Cook Incorporated | $500.00 | 2019 | |
| Boston Scientific Corporation | $322.34 | 2020-2022 | |
| Bolton Medical INC | $295.41 | 2021-2024 | Treo Abdominal Stent-Graft System |
| Angiodynamics, INC. | $262.02 | 2021-2025 | Auryon Laser System 100-120 Vac |
| Nuvasive, INC. | $167.72 | 2022-2023 | Alif |
| Silk Road Medical, INC. | $85.05 | 2022 | |
| Medistim USA, INC. | $70.23 | 2023 | Miraq |
| Inari Medical, INC. | $59.49 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $56.20 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbvie INC. | $42.42 | 2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $40.89 | 2023 | Hydro Lemaitre Valvulotome, Restoreflow |
| Pfizer INC. | $37.45 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $26.96 | 2022 | |
| Daiichi Sankyo INC. | $25.90 | 2023 | Injectafer |
| Amarin Pharma, INC. | $20.87 | 2021 | |
| Integra Lifesciences Corporation | $18.79 | 2022 | |
| Davol INC. | $16.69 | 2024 | Phasix Mesh |
| Smith+Nephew, INC. | $16.10 | 2024 | Renasys Touch |
| Endologix LLC | $14.96 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.75 | 2021 | |
| Amgen INC. | $12.10 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $3.13 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitin Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.